23andMe is a game changing human genome research company using human saliva to trace ancestry and predict / prevent complex genetic disorder risks.

Other investors include Sequoia Capital, Fidelity Investments, Johnson and Johnson, Roche Ventures, Casdin Capital, Wuxi Ventures, Xfund, Illumina, Google Ventures and US Government’s National Institutes of Health.